Assessing the impact of PD-1/PD-L1 inhibitors on health and budget in Belgium

被引：0
|
作者：
van Bavel, J. [1 ]
Lucherini, S. [2 ]
Vermeersch, S. [3 ]
Abreu, A. Bento [3 ]
Davies, N. [2 ]
Okhuoya, P. [2 ]
Pellisier, J. [4 ]
Roediger, A. [3 ]
机构：
[1] Merck USA, Charlotte, NC USA
[2] Adelphi Values UK, London, England
[3] MSD Belgium, Brussels, Belgium
[4] Merck USA, Chicago, IL USA
来源：
EUROPEAN JOURNAL OF PUBLIC HEALTH | 2018年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：439 / 439
页数：1
相关论文
共 50 条
  • [1] Projecting the budget and health impact of PD-1/PD-L1 inhibitors in Slovenia
    van Bavel, J.
    Lucherini, S.
    Rajer, M.
    Jovanovic, S. Derviskadic
    Krizaj, Z.
    Burnik, T.
    Davies, N.
    Toghanian, S.
    Pellisier, J.
    Roediger, A.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2018, 28 : 438 - 438
  • [2] Assessing the impact of anti PD-1/PD-L1 inhibitors on cancer care health and budget in Ireland
    Browne, I. M.
    Weadick, C.
    Duffy, A. G.
    ANNALS OF ONCOLOGY, 2021, 32 : S1107 - S1107
  • [3] Projecting the Budget and Health Impact of the PD-1/PD-L1 inhibitors to inform budget planning.
    van Bavel, J.
    Lucherini, S.
    Davies, N.
    Okhuoya, P.
    Pellisier, J.
    Roediger, A.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2018, 28 : 76 - 76
  • [4] Budget and Health Impact of the PD-1/PD-L1 inhibitor class in Austria
    van Bavel, J.
    Lucherini, S.
    Zeilinski, C.
    Walters, E.
    Eckart, G.
    Davies, N.
    Okhuoya, P.
    Pellisier, J.
    Roediger, A.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2018, 28 : 438 - 438
  • [5] PD-1/PD-L1 inhibitors
    Sunshine, Joel
    Taube, Janis M.
    CURRENT OPINION IN PHARMACOLOGY, 2015, 23 : 32 - 38
  • [6] ESTIMATING THE BUDGET AND HEALTH IMPACT OF THE PD-1/PD-L1 INHIBITOR CLASS IN SWITZERLAND
    Guggisberg, P.
    Huwiler, S.
    Urbinello, D.
    Rachev, B.
    Swales, O.
    Nagda, N.
    Lucherini, S.
    VALUE IN HEALTH, 2020, 23 : S459 - S459
  • [7] ASSESSING THE IMPACT OF ANTI-PD-1/PD-L1 INHIBITORS ON CANCER CARE HEALTH AND BUDGET IN GREECE
    Ktena, D.
    Dalakaki, E.
    Dimitriadis, I
    Mountain, G.
    Hughes, R.
    Clarke-Melville, S.
    Roediger, A.
    Naoum, P.
    Athanasakis, K.
    VALUE IN HEALTH, 2022, 25 (12) : S267 - S267
  • [8] Assessing the impact of anti-PD-1/PD-L1 inhibitors on cancer care health and budget in Ireland.
    Browne, Iseult
    Weadick, Catherine
    Duffy, Austin G.
    Doig, Harriet
    Bradley, Eoin
    Bell, Elizabeth
    Nagda, Nirav
    Lucherini, Stefano
    Murphy, Aileen
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [9] PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer
    Monneur, Audrey
    Goncalves, Anthony
    Bertucci, Francois
    BULLETIN DU CANCER, 2018, 105 (03) : 261 - 272
  • [10] PD-1/PD-L1 Inhibitors in Cervical Cancer
    Liu, Yuncong
    Wu, Li
    Tong, Ruizhan
    Yang, Feiyue
    Yin, Limei
    Li, Mengqian
    You, Liting
    Xue, Jianxin
    Lu, You
    FRONTIERS IN PHARMACOLOGY, 2019, 10
12345